WallStreetZenWallStreetZen

NASDAQ: THRD
Third Harmonic Bio Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

THRD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$30.8M
Current Profit Margin
0%

THRD Return on Equity

Current Company
-11.2%
Current Industry
-63.5%
Current Market
188%
THRD's Return on Equity (-11.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when THRD announces earnings.

THRD Return on Assets

Current Company
-10.8%
Current Industry
2.9%
THRD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

THRD Return on Capital Employed

Current Company
-11.32%
Current Industry
19.5%
THRD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

THRD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
THRD$0.00-$30.23M-$30.82MN/AN/A
FATE$63.53M-$142.65M-$160.93M+68.05%N/A
AVBP$0.00-$69.33M-$69.33MN/AN/A
URGN$82.71M-$81.90M-$102.24M+136.08%N/A
PROK$0.00-$25.61M-$35.47MN/AN/A
View Top Biotech Stocks

THRD earnings dates

Next earnings date
May 9, 2024

Third Harmonic Bio Earnings & Revenue FAQ

What were THRD's earnings last quarter?

On Invalid Date, Third Harmonic Bio (NASDAQ: THRD) reported Q4 2023 earnings per share (EPS) of -$0.17, up 111.04% year over year. Total Third Harmonic Bio earnings for the quarter were -$6.84 million. In the same quarter last year, Third Harmonic Bio's earnings per share (EPS) was $1.54.

If you're new to stock investing, here's how to buy Third Harmonic Bio stock.

What was THRD's earnings growth in the past year?

As of Q2 2024, Third Harmonic Bio's earnings has grown year over year. Third Harmonic Bio's earnings in the past year totalled -$30.82 million.

What is THRD's earnings date?

Third Harmonic Bio's earnings date is Invalid Date. Add THRD to your watchlist to be reminded of THRD's next earnings announcement.

What was THRD's revenue last quarter?

On Invalid Date, Third Harmonic Bio (NASDAQ: THRD) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Third Harmonic Bio's revenue was $0.00.

What was THRD's revenue growth in the past year?

As of Q2 2024, Third Harmonic Bio's revenue has grown null year over year. Third Harmonic Bio's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.